The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-amino-8-(2-fluoro-6-methoxyphenyl)-N-propylcinnoline-3-carboxamide ID: ALA1783282
Cas Number: 942437-37-8
PubChem CID: 23581869
Product Number: A412213, Order Now?
Max Phase: Phase
Molecular Formula: C19H19FN4O2
Molecular Weight: 354.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: Azd7325 | AZD-7325|942437-37-8|4-amino-8-(2-fluoro-6-methoxyphenyl)-N-propylcinnoline-3-carboxamide|AZD7325|UNII-KNM216XOUH|KNM216XOUH|CHEMBL1783282|KYDURMHFWXCKMW-UHFFFAOYSA-N|GTPL7712|SCHEMBL1962584|AZD 7325 [WHO-DD]|AZD 7325|BCP29554|EX-A3618|BDBM50418481|MFCD21337369|AKOS037649295|AZD 7325; AZD7325|DB13994|SB17497|BS-17902|HY-111052|CS-0034076|NS00072939|D81581|Q27074785|4-amino-8-(2-fluoro-6-methoxy-phenyl)-N-propyl-cinnoline-3-carboxamide|4-Amino-8-(2-fluoro-6-methoxy-phenyl)-N-propylcinno Show More⌵
Canonical SMILES: CCCNC(=O)c1nnc2c(-c3c(F)cccc3OC)cccc2c1N
Standard InChI: InChI=1S/C19H19FN4O2/c1-3-10-22-19(25)18-16(21)12-7-4-6-11(17(12)23-24-18)15-13(20)8-5-9-14(15)26-2/h4-9H,3,10H2,1-2H3,(H2,21,23)(H,22,25)
Standard InChI Key: KYDURMHFWXCKMW-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
-4.5598 -12.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5609 -12.9523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8461 -13.3652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8479 -11.7122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1325 -12.1213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1291 -12.9544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4099 -13.3657 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4168 -11.6995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4213 -10.8746 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8476 -14.1902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6855 -12.1146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6912 -12.9507 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9711 -11.7020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2566 -12.1143 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9713 -10.8770 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.4578 -11.7017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1724 -12.1140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8868 -11.7014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5639 -14.5961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5657 -15.4203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8515 -15.8349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1339 -15.4193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1356 -14.5964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2763 -14.1800 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.2721 -13.3550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4226 -14.1813 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
11 13 1 0
3 6 2 0
13 14 1 0
1 2 2 0
13 15 2 0
5 8 1 0
14 16 1 0
6 7 1 0
16 17 1 0
7 12 2 0
17 18 1 0
11 8 2 0
10 19 1 0
5 4 2 0
19 20 2 0
8 9 1 0
20 21 1 0
4 1 1 0
21 22 2 0
3 10 1 0
22 23 1 0
23 10 2 0
11 12 1 0
19 24 1 0
5 6 1 0
24 25 1 0
23 26 1 0
M END
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: YesAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 354.39Molecular Weight (Monoisotopic): 354.1492AlogP: 3.17#Rotatable Bonds: 5Polar Surface Area: 90.13Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.92CX LogP: 2.94CX LogD: 2.94Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.73Np Likeness Score: -1.07
References 1. Alhambra C, Becker C, Blake T, Chang AH, Damewood JR, Daniels T, Dembofsky BT, Gurley DA, Hall JE, Herzog KJ, Horchler CL, Ohnmacht CJ, Schmiesing RJ, Dudley A, Ribadeneira MD, Knappenberger KS, Maciag C, Stein MM, Chopra M, Liu XF, Christian EP, Arriza JL, Chapdelaine MJ.. (2011) Development and SAR of functionally selective allosteric modulators of GABAA receptors., 19 (9): [PMID:21498079 ] [10.1016/j.bmc.2011.03.035 ] 2. Unpublished dataset, 3. Maramai S, Benchekroun M, Ward SE, Atack JR.. (2020) Subtype Selective γ-Aminobutyric Acid Type A Receptor (GABAA R) Modulators Acting at the Benzodiazepine Binding Site: An Update., 63 (7): [PMID:31738537 ] [10.1021/acs.jmedchem.9b01312 ] 4. Hall A, Chanteux H, Ménochet K, Ledecq M, Schulze MED.. (2021) Designing Out PXR Activity on Drug Discovery Projects: A Review of Structure-Based Methods, Empirical and Computational Approaches., 64 (10.0): [PMID:34003642 ] [10.1021/acs.jmedchem.0c02245 ] 5. EUbOPEN. (2023) EUbOPEN Chemogenomics Library - IncuCyte, [10.6019/CHEMBL5303304 ]